FoxHollow Integration Problems Plague ev3 In First Quarter
This article was originally published in The Gray Sheet
Executive Summary
Endovascular device firm ev3's failure to meet first-quarter 2008 revenue targets is being blamed on unexpected challenges in assimilating the FoxHollow Technologies sales force
You may also be interested in...
Covidien Runs Familiar But Different Plays to Build Vascular Franchise
Covidien Ltd. continues to build its vascular global business unit with the acquisition of peripheral leader ev3 Inc.
Covidien Runs Familiar But Different Plays to Build Vascular Franchise
Covidien Ltd. continues to build its vascular global business unit with the acquisition of peripheral leader ev3 Inc.
People In Brief
Medtronic names new diabetes exec: Pediatric endocrinologist Francine Kaufman will join Medtronic's diabetes business in June as VP of global medical affairs. Kaufman, who will report to the president of the diabetes unit Chris O'Connell, will be a "key architect of the company's global diabetes strategy, as well as a leading voice for multi-disciplinary medical strategy across Medtronic," firm said in a Nov. 24 announcement. She is and will remain a professor at the University of Southern California Keck School of Medicine and is a former president of the American Diabetes Association. Kaufman succeeds Alan Marcus